INST scientists find natural protein that can reshape future of electronic materials

(Photo: PIB)

New Delhi, (IANS) A team of scientists from Institute of Nano Science and Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology (DST), have discovered semiconductor property of a known self-assembling bacterial shell protein could pave the way for safe, environmentally friendly electronics -- from mobile phones and smart watches to medical instruments and environmental sensors.

Traditional semiconductor materials, such as silicon, are valuable technological tools; however, they also have limitations. They are rigid, require high-energy processing, and contribute to the growing problem of electronic waste. Thus, there is increasing demand for sustainable, soft, and biocompatible electronics (wearables, implantable, green sensors).

The INST scientists experimented with self-assembling bacterial shell proteins to explore whether the proteins that naturally form stable, large flat 2D sheets with built-in electron density patterns and aromatic residues could be intrinsically photoactive.

They found that when the proteins form flat, sheet-like films, they absorb UV light and generate an electrical current without any added dyes, metals, or external power and act as light-driven, scaffold-free semiconductors, much like the materials used in electronic circuits and sensors.

Further, the team discovered that these proteins naturally arrange themselves into thin, sheet-like structures. When UV light shines on them, tiny electrical charges begin to move across the protein surface.

“This happens because the proteins contain tyrosine, a natural amino acid that can release electrons when excited by light. As these electrons and protons move, the protein sheet produces an electrical signal -- similar to how a miniature solar cell would operate. This light-driven effect relies on the protein’s internal order and does not require any synthetic additives or high-temperature manufacturing,” said the team led by Dr. Sharmistha Sinha, together with student researchers Silky Bedi and S. M. Rose.

“The discovery opens up exciting possibilities for real-world applications. Because the material is flexible and body-friendly, it could be used to create wearable health monitors, skin-safe UV-detection patches, and implantable medical sensors that work safely inside the human body,” the team said.

In the paper, published in the journal Chemical Science of the Royal Society of Chemistry, the team could also be used in temporary or disposable environmental sensors, such as pollution detectors or sunlight trackers, that naturally break down after use without harming the environment.Families, patients, and consumers may one day benefit from soft, comfortable, and environmentally responsible devices that integrate smoothly into daily life. INST scientists find natural protein that can reshape future of electronic materials | MorungExpress | morungexpress.com
Read More........

India launches world’s 1st clinical trial to test Ayurveda with TB treatment


(File Photo/IANS)

New Delhi, (IANS) On the occasion of World Tuberculosis Day, India announced the world’s first clinical study to scientifically evaluate Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT), the government said on Tuesday.

The collaborative clinical study between the Department of Biotechnology and the Ministry of Ayush will enrol 1,250 newly diagnosed tuberculosis patients across eight institutions to evaluate Ayurveda as an adjunct to standard treatment, focusing on body weight, nutritional outcomes, disease progression, quality of life, safety, and tolerability.

Union MoS for Science & Technology Jitendra Singh said the study reflects the spirit of “whole-of-science,” approach by integrating biotechnology and Ayurveda; “whole-of-government” approach through collaboration between ministries.

DG, CCRAS, Prof. Vaidya Rabinarayan Acharya said the initiative has progressed through consultations, protocol finalisation, and approvals.

Director, BRIC-NII, Dr. Debasisa Mohanty said the study will examine tuberculosis-associated cachexia as an immune-metabolic condition, using advanced tools such as DEXA, MRI, immune profiling, metabolomics, and single-cell RNA sequencing to understand changes in body composition, immune function, and energy metabolism.

It is aimed to assess how integrative interventions influence recovery and long-term outcomes, the statement from the Ministry of Science & Technology said.

Minister Jitendra Singh said India, which accounts for nearly 25 per cent of the global TB burden, saw a 21 per cent drop in a decade in tuberculosis incidence to about 187 cases per 1,00,000 population in 2024.

“The decline in TB incidence is an outcome of India’s dedicated and innovative efforts. Through a collective spirit, we will keep working towards a TB-free India,” he quoted Prime Minister Narendra Modi.

India has adopted an ambitious and accelerated pathway towards TB elimination, strengthening early diagnosis, universal drug susceptibility testing, digital adherence technologies, and patient-centric care under the National TB Elimination Programme, the minister said.

He pointed out the reciprocal relationship between TB and conditions such as diabetes, where each can aggravate the other, making integrated approaches essential for effective disease management.He also referred to the RePORT India programme, one of the largest TB research consortia, with over 4,500 enrolled TB patients and over 5,000 household contacts, generating evidence relevant for global policy frameworks, including WHO guidelines on nutrition and tuberculosis. India launches world’s 1st clinical trial to test Ayurveda with TB treatment | MorungExpress | morungexpress.com
Read More........